HRP980267A2 - Tetrazoles - Google Patents

Tetrazoles

Info

Publication number
HRP980267A2
HRP980267A2 HR9709972.5A HRP980267A HRP980267A2 HR P980267 A2 HRP980267 A2 HR P980267A2 HR P980267 A HRP980267 A HR P980267A HR P980267 A2 HRP980267 A2 HR P980267A2
Authority
HR
Croatia
Prior art keywords
piperazinyl
compound
phenyl
dimethyl
image
Prior art date
Application number
HR9709972.5A
Other languages
English (en)
Croatian (hr)
Inventor
Graham Nigel Maw
Original Assignee
Graham Nigel Maw
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Graham Nigel Maw filed Critical Graham Nigel Maw
Publication of HRP980267A2 publication Critical patent/HRP980267A2/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Surface Acoustic Wave Elements And Circuit Networks Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HR9709972.5A 1997-05-19 1998-05-19 Tetrazoles HRP980267A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9709972.5A GB9709972D0 (en) 1997-05-19 1997-05-19 Tetrazoles

Publications (1)

Publication Number Publication Date
HRP980267A2 true HRP980267A2 (en) 1999-02-28

Family

ID=10812431

Family Applications (1)

Application Number Title Priority Date Filing Date
HR9709972.5A HRP980267A2 (en) 1997-05-19 1998-05-19 Tetrazoles

Country Status (19)

Country Link
US (1) US6514975B1 (de)
EP (1) EP0983251B1 (de)
JP (1) JP2000513024A (de)
AR (1) AR015679A1 (de)
AT (1) ATE269852T1 (de)
AU (1) AU7644998A (de)
BR (1) BR9809648A (de)
CA (1) CA2290501C (de)
DE (1) DE69824724T2 (de)
DK (1) DK0983251T3 (de)
ES (1) ES2221985T3 (de)
GB (1) GB9709972D0 (de)
HR (1) HRP980267A2 (de)
MA (1) MA26499A1 (de)
PA (1) PA8451601A1 (de)
PT (1) PT983251E (de)
TN (1) TNSN98066A1 (de)
WO (1) WO1998052929A1 (de)
ZA (1) ZA984158B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985880A (en) 1996-06-05 1999-11-16 Delta Pharmaceuticals Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds
GB9804734D0 (en) * 1998-03-05 1998-04-29 Pfizer Ltd Compounds
US6054623A (en) 1998-12-18 2000-04-25 Alliedsignal Inc. Hydroxythiol grignard reaction synthesis
US6503905B1 (en) 1998-12-29 2003-01-07 Pfizer Inc 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
US6455055B1 (en) 1999-02-12 2002-09-24 The Procter & Gamble Company Cosmetic compositions
PE20010623A1 (es) * 1999-10-05 2001-07-07 Gruenenthal Chemie Uso de (+)-tramadol y/o o-demetiltramadol para tratamiento de urgencia urinaria incrementada y/o incontinencia urinaria
EP1359146B1 (de) 2000-10-31 2008-04-09 Rensselaer Polytechnic Institute 4-arylpiperidine als opioidrezeptorbindende agenzien
ES2278065T3 (es) 2001-10-15 2007-08-01 Janssen Pharmaceutica N.V. Nuevos derivados de 4-fenil-4-(1h-imidazol-2-il)-piperidina sustituida y su uso como agonistas selectivos de opioides delta no peptidos.
WO2003037342A1 (en) * 2001-10-29 2003-05-08 Ardent Pharmaceuticals, Inc. Method of treating depression with delta receptor agonist compounds
EP1469850B1 (de) 2002-01-02 2013-01-02 Versi Group, LLC Verfahren zur behandlung von sexuellen funktionsstörungen mit delta opioid-rezeptor-agonist-verbindungen
JP4665379B2 (ja) * 2002-06-28 2011-04-06 Ｄｉｃ株式会社 ヘリカルツイスティングパワーの増大方法、光学活性化合物、それを含有した液晶組成物及び液晶表示素子
TW200504033A (en) * 2002-10-23 2005-02-01 Procter & Gamble Melanocortin receptor ligands
US20090297611A1 (en) * 2003-07-31 2009-12-03 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or vcam inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050026879A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or VCAM inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20080045610A1 (en) * 2004-09-23 2008-02-21 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
CA2580694A1 (en) * 2004-09-23 2006-03-30 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
CA2643677C (en) * 2005-04-14 2015-06-23 Mount Cook Biosciences, Inc. Compositions of novel opioid compounds and method of use thereof
US7210814B2 (en) * 2005-04-29 2007-05-01 Ultradent Products, Inc. Dental curing light with specially arranged LEDs
US20100029681A1 (en) * 2006-05-26 2010-02-04 Hassan Pajouhesh Heterocyclic compounds as calcium channel blockers
SG172685A1 (en) * 2006-06-28 2011-07-28 Amgen Inc Glycine transporter-1 inhibitors
US8573616B2 (en) 2009-05-29 2013-11-05 Hydema Produktion A/S Suspension system with inclination stabilization
AU2010326676B2 (en) 2009-12-04 2013-03-14 Alkermes Pharma Ireland Limited Morphinan derivatives for the treatment of drug overdose
JP5964809B2 (ja) 2010-03-22 2016-08-03 レンセラール ポリテクニック インスティチュート オピオイド受容体リガンドとしてのカルボキサミド基を含有するモルヒネ誘導体
PL3446565T3 (pl) 2010-08-23 2024-04-02 Alkermes Pharma Ireland Limited Sposoby leczenia przyrostu masy ciała wywołanego lekami przeciwpsychotycznymi
US9029543B2 (en) 2011-04-05 2015-05-12 Alkermes, Inc. Process for the synthesis of quaternary amine compounds
RS56181B1 (sr) 2011-06-29 2017-11-30 Alkermes Inc Periferno delujuća opioidna jedinjenja
US9211293B2 (en) 2011-12-15 2015-12-15 Alkermes Pharma Ireland Limited Opioid agonist antagonist combinations
PL3153171T3 (pl) 2011-12-15 2019-02-28 Alkermes Pharma Ireland Limited Samidorfan (alks 33) w połączeniu z buprenorfiną do leczenia zaburzeń depresyjnych
US9656961B2 (en) 2013-05-24 2017-05-23 Alkermes Pharma Ireland Limited Methods for treating depressive symptoms
WO2014190270A1 (en) 2013-05-24 2014-11-27 Alkermes Pharma Ireland Limited Morphan and morphinan analogues, and methods of use
CN106588873B (zh) * 2016-11-21 2019-11-12 云南省药物研究所 一种三芳基二甲基哌嗪乙二磺酸盐的多晶型物及其制备方法和应用
EP4243768A1 (de) 2020-11-12 2023-09-20 Alkermes Pharma Ireland Limited Mehrschichttablette mit sofortiger freisetzung

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3453285A (en) * 1967-11-29 1969-07-01 Miles Lab Tetrazolyl alkanoic acids
US5807858A (en) * 1996-06-05 1998-09-15 Delta Pharmaceutical, Inc. Compositions and methods for reducing respiratory depression
GB9202238D0 (en) * 1992-02-03 1992-03-18 Wellcome Found Compounds
EP0585500A1 (de) * 1992-09-04 1994-03-09 Merrell Dow Pharmaceuticals Inc. Diaryl-Piperazinacetamid als antimuscarinische Wirkstoffe
RU2133744C1 (ru) * 1993-07-30 1999-07-27 Дельта Фармасьютикалз, Инк. Пиперазиновые соединения
JPH07247274A (ja) * 1994-03-10 1995-09-26 Wakamoto Pharmaceut Co Ltd ピバル酸 テトラゾリルフェニルエステル誘導体、それらを有効成分として含有するエラスターゼ阻害剤及び肺障害治療剤
SE9504661D0 (sv) * 1995-12-22 1995-12-22 Astra Pharma Inc New compounds
USH2007H1 (en) * 1996-01-19 2001-12-04 Fmc Corporation Insecticidal N-heterocyclylalkyl-or N-[(polycyclyl)alkyl]-N′substituted piperazines

Also Published As

Publication number Publication date
EP0983251A1 (de) 2000-03-08
GB9709972D0 (en) 1997-07-09
MA26499A1 (fr) 2004-12-20
DE69824724D1 (de) 2004-07-29
CA2290501A1 (en) 1998-11-26
BR9809648A (pt) 2000-07-11
AR015679A1 (es) 2001-05-16
WO1998052929A1 (en) 1998-11-26
ZA984158B (en) 1999-11-19
CA2290501C (en) 2003-07-08
ES2221985T3 (es) 2005-01-16
PT983251E (pt) 2004-08-31
PA8451601A1 (es) 2000-05-24
US6514975B1 (en) 2003-02-04
EP0983251B1 (de) 2004-06-23
JP2000513024A (ja) 2000-10-03
DE69824724T2 (de) 2005-08-25
DK0983251T3 (da) 2004-09-27
AU7644998A (en) 1998-12-11
ATE269852T1 (de) 2004-07-15
TNSN98066A1 (fr) 2005-03-15

Similar Documents

Publication Publication Date Title
US6514975B1 (en) Anti-inflammatory piperazinyl-benzyl-tetrazole derivatives and intermediates thereof
US6200978B1 (en) Compounds as delta opioid agonists
US5494926A (en) 2/3-(heterocyclic alkyl amino)-1-(subst.-phenyl-methoxy)-ethanes/propanes as tachykinin-receptor antagonists
CN112805005B (zh) 甲状腺素受体β促效剂化合物
EP1494671B1 (de) 1-(4-piperidinyl)benzimidazolone als histamin h3 antagonisten
US6060469A (en) Spiro-piperidine derivatives and their use as tachykinin antagonists
US5693657A (en) Heterocyclic-substituted alkyl amide acat inhibitors
ES2298513T3 (es) Derivados de tiazol como antagonistas del receptor de taquicinina.
ES2221204T3 (es) Derivados de amidas o sales de los indicados derivados.
US5034539A (en) Histamine derivative, process for preparing it and its therapeutic use
JPH0625134B2 (ja) 新規な複素環化合物
US5521175A (en) Benzodiazepine derivatives
US5478933A (en) Benzodiazepine derivatives and their use as antagonists of cholecystokinin and/or gastrin receptors
EP0810991B1 (de) 1-aryl-2-acylamino-ethan-verbindungen und ihre verwendung als neurokinin- insbesondere als neurokinin-1-antagonisten
JP2008525401A (ja) 治療薬
EP0609306A1 (de) Benzodiazepinderivate und ihre verwendung als antagonisten von cholecystokinin und/oder gastrin rezeptoren
LV12314B (en) Cholecystokinin antagonists
JP2007531723A (ja) 治療薬
EP0595980A1 (de) Benzodiazepinderivate, diese enthaltende zusammensetzungen und ihre verwendung in der heilkunde
PL183712B1 (pl) Nowy związek, pochodna oksadiazolu o działaniu prokinetycznym, kompozycja farmaceutyczna i sposób wytwarzania pochodnej oksadiazolu
KR100248643B1 (ko) 아릴 및 헤테로아릴 알콕시나프탈렌 유도체
JPH07233162A (ja) イミダゾリジノン誘導体とその酸付加塩及び老年性痴呆症の治療薬
US5696110A (en) Benzodiazepine derivatives and their use as antagonists of cholecystokinin and/or gastrin receptors
MXPA99010800A (en) Anti-inflammatory piperazinyl-benzyl-tetrazole derivatives and intermediates thereof
US4958023A (en) 2-pyridinecarbothioamides, processes for preparation thereof and pharmaceutical compositions comprising the same

Legal Events

Date Code Title Description
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
A1OB Publication of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 19990519

Year of fee payment: 2

ODBC Application rejected